Pear Therapeutics Stock
Digital Therapeutics Platform
Sign up today and learn more about Pear Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Pear Therapeutics Stock
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to help treat disease and enhance the efficacy of pharmaceuticals. The company's platform aims to combine novel digital interventions with drugs to enhance efficacy, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians and cost-effective services for payers. The company has three FDA-approved products for substance use disorders, opioid use disorders, and insomnia.Â
Pear Therapeutics was founded in 2013 and is headquartered in Boston, Massachusetts. Notable investors include Softbank Vision Fund, Temasek Holdings, and Perceptive Advisors.
Investors
QUAD Investment Management
Bridge Builders Collaborative
5AM Ventures
Novartis
Forth Management
Funding History
February 2016 | $18.7M |
---|---|
December 2017 | $51.0M |
December 2018 | $64.4M |
December 2020 | $32.0M |
December 2020 | $107M |
Management
Chief Executive Officer
Corey McCann
Chief Financial Officer
Chris Guiffre
Press
massdevice - Oct, 13 2021
Massachusetts offers Medicaid coverage for Pear Therapeutics’ digital therapeuticsshar - Oct, 13 2021
MassHealth to cover Pear Therapeutics' reSET and reSET-Odrugdeliverybusiness - Sep, 16 2021
Pear Therapeutics touts real-world data for reSET-O prescription digital therapeuticdrugdeliverybusiness - Jul, 14 2021
Pear Therapeutics touts 9-month data for reSET-Oow - Jun, 22 2021
Pear Therapeutics to go public via SPAC merger